Despite the number of times a number of posters on a number of threads have repeatedly explained that Remdesivir is an anti-viral (prevents viral replication) and Rememstemcel-L is not an anti-viral but treats the consequences of Covid-ARDS and pneumonia @whytee still comes back with "Well they are competing, but its impossible to judge how successfully unless there is a head to head controlled trial, which probably both companies would not want..."
A head to head controlled trial of these two products is an impossibility. An absurdity. They are not competing. They cannot compete. Be like having a head to head trial of aspirin vs penicillin. To do what?
Just one of the explanatory posts I refer to is one of mine from just yesterday, Post #: 44092864 I put this link here to save me going through it all again.
I'm fairly sure most posters understand this and find it repetitive. In fact I'd be surprised if whytee doesn't understand it also and I wonder why he tries to sow confusion.
- Forums
- ASX - By Stock
- MSB
- Gilead vs Mesoblast
Gilead vs Mesoblast, page-27
-
- There are more pages in this discussion • 248 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 71720 | 94.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 10463 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65720 | 0.940 |
3 | 31070 | 0.935 |
4 | 85753 | 0.930 |
2 | 9000 | 0.925 |
5 | 75776 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 10463 | 1 |
0.950 | 50000 | 2 |
0.955 | 64000 | 1 |
0.960 | 30220 | 3 |
0.965 | 44050 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |